News | March 29, 2022
Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series
Data to establish the safety profile and human dose of vaccine candidate
Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder
These new chemical entities are covered by composition of matter patent applications. Financial terms of the deal were not disclosed
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
Subscribe To Our Newsletter & Stay Updated
